Michael Dodds

Michael Dodds is the Executive Director at Certara and Vice President of Quantitative Sciences at Lumen Bioscience. With a strong focus on pharmacometrics, Michael has contributed significantly to drug development through mathematical modeling of drug interactions and patient outcomes. Michael's professional journey includes roles at ZymoGenetics and Amgen, where extensive expertise in pharmacokinetics and simulation guided critical drug development decisions. They hold a Ph.D. in Bioengineering from the University of Washington and multiple degrees in Biochemistry and Chemical Engineering from North Carolina State University.